Related Experiment Videos
Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects
Neurology
|October 1, 1984
Summary
Valproic acid (VPA) treatment depletes essential trace metals like zinc and selenium. This may increase the risk of liver damage, particularly in children, due to reduced protection against oxidative stress.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Anticonvulsant valproic acid (VPA) treatment has been linked to potential alterations in trace metal status.
- Hepatotoxicity is a known side effect of VPA, particularly in pediatric patients.
Purpose of the Study:
- To investigate the effect of valproic acid administration on trace metal levels in rats.
- To examine the relationship between chronic VPA treatment and plasma selenium concentrations in patients.
- To explore the potential role of selenium depletion in VPA-associated hepatotoxicity.
Main Methods:
- Rats were administered VPA for one week to assess plasma and hepatic trace metal changes.
- Plasma selenium levels were measured in patients receiving chronic VPA monotherapy.
Main Results:
- VPA administration led to significant depletion of zinc and selenium in rat plasma.
- Hepatic selenium levels were reduced by approximately one-third in rats treated with VPA.
- Patients on chronic VPA treatment exhibited decreased plasma selenium levels.
Conclusions:
- Valproic acid treatment can cause significant depletion of essential trace metals, specifically zinc and selenium.
- Reduced selenium concentrations may impair the body's defense against peroxidative damage, potentially contributing to VPA-induced hepatotoxicity in children.
- Further research is warranted to elucidate the precise mechanisms and clinical implications of VPA's effect on trace metal metabolism.